Tags

Type your tag names separated by a space and hit enter

[Treatment of peyronie's disease with para-aminobenzoacidic potassium (POTOBA) (author's transl)].
Urologe A. 1978 Jul; 17(4):224-7.U

Abstract

A total of 214 urologists treated 2653 cases of Peyronie's Disease with para-aminobenzoacidic potassium (POTOBA). The treatment was successful in 57.3% and unsuccessful in 42.7% of the cases; 246 patients (9.3%) were 'cured. Particular prescriptions intended to increase gastric tolerance and thereby guarantee long-term use of the medication are pointed to as a prerequisite to successful therapy. Practical advice is presented on how to interest patients in carrying out long-term treatment themselves.

Authors

No affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

308273

Citation

Hasche-Klünder, R. "[Treatment of Peyronie's Disease With Para-aminobenzoacidic Potassium (POTOBA) (author's Transl)]." Der Urologe. Ausg. A, vol. 17, no. 4, 1978, pp. 224-7.
Hasche-Klünder R. [Treatment of peyronie's disease with para-aminobenzoacidic potassium (POTOBA) (author's transl)]. Urologe A. 1978;17(4):224-7.
Hasche-Klünder, R. (1978). [Treatment of peyronie's disease with para-aminobenzoacidic potassium (POTOBA) (author's transl)]. Der Urologe. Ausg. A, 17(4), 224-7.
Hasche-Klünder R. [Treatment of Peyronie's Disease With Para-aminobenzoacidic Potassium (POTOBA) (author's Transl)]. Urologe A. 1978;17(4):224-7. PubMed PMID: 308273.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Treatment of peyronie's disease with para-aminobenzoacidic potassium (POTOBA) (author's transl)]. A1 - Hasche-Klünder,R, PY - 1978/7/1/pubmed PY - 1978/7/1/medline PY - 1978/7/1/entrez SP - 224 EP - 7 JF - Der Urologe. Ausg. A JO - Urologe A VL - 17 IS - 4 N2 - A total of 214 urologists treated 2653 cases of Peyronie's Disease with para-aminobenzoacidic potassium (POTOBA). The treatment was successful in 57.3% and unsuccessful in 42.7% of the cases; 246 patients (9.3%) were 'cured. Particular prescriptions intended to increase gastric tolerance and thereby guarantee long-term use of the medication are pointed to as a prerequisite to successful therapy. Practical advice is presented on how to interest patients in carrying out long-term treatment themselves. SN - 0340-2592 UR - https://wwww.unboundmedicine.com/medline/citation/308273/[Treatment_of_peyronie's_disease_with_para_aminobenzoacidic_potassium__POTOBA___author's_transl_]_ L2 - https://www.diseaseinfosearch.org/result/5697 DB - PRIME DP - Unbound Medicine ER -